Cargando…

Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay

Cervical cancer is a significant public health problem, especially in low- and middle-income countries, where women have little access to cervical cancer screening; consequently 80% of cervical cancer related mortality occurs in these regions. The development of screening methods that need less infr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira, Cristina Mendes, Musselwhite, Laura W., de Paula Pantano, Naitielle, Vazquez, Fabiana Lima, Smith, Jennifer S., Schweizer, Johannes, Belmares, Michael, Possati-Resende, Júlio César, Vieira, Marcelo de Andrade, Longatto-Filho, Adhemar, Fregnani, José Humberto Tavares Guerreiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176116/
https://www.ncbi.nlm.nih.gov/pubmed/32320451
http://dx.doi.org/10.1371/journal.pone.0232105
_version_ 1783524955863908352
author de Oliveira, Cristina Mendes
Musselwhite, Laura W.
de Paula Pantano, Naitielle
Vazquez, Fabiana Lima
Smith, Jennifer S.
Schweizer, Johannes
Belmares, Michael
Possati-Resende, Júlio César
Vieira, Marcelo de Andrade
Longatto-Filho, Adhemar
Fregnani, José Humberto Tavares Guerreiro
author_facet de Oliveira, Cristina Mendes
Musselwhite, Laura W.
de Paula Pantano, Naitielle
Vazquez, Fabiana Lima
Smith, Jennifer S.
Schweizer, Johannes
Belmares, Michael
Possati-Resende, Júlio César
Vieira, Marcelo de Andrade
Longatto-Filho, Adhemar
Fregnani, José Humberto Tavares Guerreiro
author_sort de Oliveira, Cristina Mendes
collection PubMed
description Cervical cancer is a significant public health problem, especially in low- and middle-income countries, where women have little access to cervical cancer screening; consequently 80% of cervical cancer related mortality occurs in these regions. The development of screening methods that need less infrastructure thus represents an urgent medical need. The study aims to compare the detection rates of high-risk human papillomavirus 16 and 18 E6 oncoprotein in urine, vaginal self-collected, and cervical scrapes of women using the OncoE6(™) Cervical Test and compare the HPV16 and/or HPV18 E6 detection rates with the HPV DNA testing. Paired urine, vaginal self-collected and cervical specimens were collected from 124 women who participated in cervical cancer screening or treatment in this proof-of-concept study and underwent to HPV16/18-E6 testing and high-risk HPV DNA testing prior to treatment of cervical neoplasia or cancer. Concordance between urinary, vaginal and cervical HPV16/18-E6 and HPV-DNA testing was evaluated for patients classified as negative group (<CIN2) and histological positive group (CIN2, CIN3 and invasive carcinoma). Overall, HPV16/18-E6 oncoprotein was detected in 30.6% of cervical samples, 20.3% of self-collected vaginal samples and 21% of urine samples. Regarding the clinical sensitivity, the HPV16/18-E6 oncoprotein was not detected in CIN2 cases, and was detected at low rates in CIN3 cases. The clinical sensitivity of the HPV16/18-E6 oncoprotein for detecting invasive cervical cancer was 70% for cervical scrapes, 55% for self-collected vaginal samples and 52% for urine samples. This study reports the urinary detection of E6 oncoprotein in vivo for the first time and our results suggest that this detection is only for invasive/microinvasive lesions. Then, further protocol development and standardization to achieve a clinical sensitivity for CIN2/3 detection close to what can be achieved for invasive lesions using the physician collected cervical is needed.
format Online
Article
Text
id pubmed-7176116
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-71761162020-05-12 Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay de Oliveira, Cristina Mendes Musselwhite, Laura W. de Paula Pantano, Naitielle Vazquez, Fabiana Lima Smith, Jennifer S. Schweizer, Johannes Belmares, Michael Possati-Resende, Júlio César Vieira, Marcelo de Andrade Longatto-Filho, Adhemar Fregnani, José Humberto Tavares Guerreiro PLoS One Research Article Cervical cancer is a significant public health problem, especially in low- and middle-income countries, where women have little access to cervical cancer screening; consequently 80% of cervical cancer related mortality occurs in these regions. The development of screening methods that need less infrastructure thus represents an urgent medical need. The study aims to compare the detection rates of high-risk human papillomavirus 16 and 18 E6 oncoprotein in urine, vaginal self-collected, and cervical scrapes of women using the OncoE6(™) Cervical Test and compare the HPV16 and/or HPV18 E6 detection rates with the HPV DNA testing. Paired urine, vaginal self-collected and cervical specimens were collected from 124 women who participated in cervical cancer screening or treatment in this proof-of-concept study and underwent to HPV16/18-E6 testing and high-risk HPV DNA testing prior to treatment of cervical neoplasia or cancer. Concordance between urinary, vaginal and cervical HPV16/18-E6 and HPV-DNA testing was evaluated for patients classified as negative group (<CIN2) and histological positive group (CIN2, CIN3 and invasive carcinoma). Overall, HPV16/18-E6 oncoprotein was detected in 30.6% of cervical samples, 20.3% of self-collected vaginal samples and 21% of urine samples. Regarding the clinical sensitivity, the HPV16/18-E6 oncoprotein was not detected in CIN2 cases, and was detected at low rates in CIN3 cases. The clinical sensitivity of the HPV16/18-E6 oncoprotein for detecting invasive cervical cancer was 70% for cervical scrapes, 55% for self-collected vaginal samples and 52% for urine samples. This study reports the urinary detection of E6 oncoprotein in vivo for the first time and our results suggest that this detection is only for invasive/microinvasive lesions. Then, further protocol development and standardization to achieve a clinical sensitivity for CIN2/3 detection close to what can be achieved for invasive lesions using the physician collected cervical is needed. Public Library of Science 2020-04-22 /pmc/articles/PMC7176116/ /pubmed/32320451 http://dx.doi.org/10.1371/journal.pone.0232105 Text en © 2020 Oliveira et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
de Oliveira, Cristina Mendes
Musselwhite, Laura W.
de Paula Pantano, Naitielle
Vazquez, Fabiana Lima
Smith, Jennifer S.
Schweizer, Johannes
Belmares, Michael
Possati-Resende, Júlio César
Vieira, Marcelo de Andrade
Longatto-Filho, Adhemar
Fregnani, José Humberto Tavares Guerreiro
Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title_full Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title_fullStr Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title_full_unstemmed Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title_short Detection of HPV E6 oncoprotein from urine via a novel immunochromatographic assay
title_sort detection of hpv e6 oncoprotein from urine via a novel immunochromatographic assay
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176116/
https://www.ncbi.nlm.nih.gov/pubmed/32320451
http://dx.doi.org/10.1371/journal.pone.0232105
work_keys_str_mv AT deoliveiracristinamendes detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT musselwhitelauraw detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT depaulapantanonaitielle detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT vazquezfabianalima detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT smithjennifers detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT schweizerjohannes detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT belmaresmichael detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT possatiresendejuliocesar detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT vieiramarcelodeandrade detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT longattofilhoadhemar detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay
AT fregnanijosehumbertotavaresguerreiro detectionofhpve6oncoproteinfromurineviaanovelimmunochromatographicassay